Revised ISS (R-ISS) for multiple myeloma
Revised ISS (R-ISS) for multiple myeloma - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
Open the Revised ISS (R-ISS) for multiple myeloma → Runs in your browser. No signup, no tracking.
What this is
Revised ISS (R-ISS) for multiple myeloma is one of 230 deterministic tools in Sophie Well's Clinical Scoring & Risk group. Revised ISS (R-ISS) for multiple myeloma - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
When to use it
Use this tool when you need a quick, citable reference. Every calculation runs entirely in your browser - no inputs leave your device, no account is required, no AI is involved. The site enforces a strict Content Security Policy and ships no analytics or third-party CDN.
References
Palumbo A, Avet-Loiseau H, Oliva S, et al. Revised International Staging System for multiple myeloma: a report from International Myeloma Working Group. J Clin Oncol. 2015;33(26):2863-2869. Read the source ↗
Worked example: Revised ISS (R-ISS) stage III (ISS III with high LDH) -- 5-year overall survival ~40% in the IMWG cohort.
Sophie Well is a reference and educational tool. Not medical, legal, or financial advice. Does not replace clinician judgment, professional billing review, or legal counsel.